Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Periostin as a modulator of chronic cardiac remodeling after myocardial infarction
Marcos F Minicucci1, Priscila P dos Santos, Bruna P M Rafacho
1Universidade Estadual Paulista (UNESP), Botucatu Medical School, Internal Medicine Department, BotucatuSP, Brazil.
Insights
Periostin levels increase after myocardial infarction, correlating with adverse cardiac remodeling and impaired function. This suggests periostin may drive detrimental changes in the chronic phase post-infarction.
Area of Science:
- Cardiovascular Research
- Extracellular Matrix Biology
- Cardiac Remodeling
Background:
- Periostin plays a role in acute cardiac repair following myocardial infarction.
- The function of periostin in chronic cardiac remodeling after myocardial infarction is not well understood.
Purpose of the Study:
- To investigate the association between tissue periostin levels and cardiac variables during chronic remodeling after myocardial infarction.
Main Methods:
- Male Wistar rats underwent either sham surgery or myocardial infarction.
- Morphological, functional, and biochemical analyses were conducted after three months.
Main Results:
- Myocardial infarction led to enlarged left ventricular areas and reduced cardiac function.
- Elevated periostin, collagen types I and III, and hydroxyproline were observed in the infarcted group.
- Periostin positively correlated with collagen III and left ventricular dimensions, and inversely with fractional area change and wall shortening velocity.
Conclusions:
- Periostin may act as a key modulator of adverse cardiac remodeling in the chronic phase after myocardial infarction in rats.
Objective:
After acute myocardial infarction, during the cardiac repair phase, periostin is released into the infarct and activates signaling pathways that are essential for the reparative process. However, the role of periostin in chronic cardiac remodeling after myocardial infarction remains to be elucidated. Therefore, the objective of this study was to investigate the relationship between tissue periostin and cardiac variables in the chronic cardiac remodeling induced by myocardial infarction.
Methods:
Male Wistar rats were assigned to 2 groups: a simulated surgery group (SHAM; n = 8) and a myocardial infarction group (myocardial infarction; n = 13). After 3 months, morphological, functional and biochemical analyses were performed. The data are expressed as means±SD or medians (including the lower and upper quartiles).
Results:
Myocardial infarctions induced increased left ventricular diastolic and systolic areas associated with a decreased fractional area change and a posterior wall shortening velocity. With regard to the extracellular matrix variables, the myocardial infarction group presented with higher values of periostin and types I and III collagen and higher interstitial collagen volume fractions and myocardial hydroxyproline concentrations. In addition, periostin was positively correlated with type III collagen levels (r = 0.673, p = 0.029) and diastolic (r = 0.678, p = 0.036) and systolic (r = 0.795, p = 0.006) left ventricular areas. Considering the relationship between periostin and the cardiac function variables, periostin was inversely correlated with both the fractional area change (r = -0.783, p = 0.008) and the posterior wall shortening velocity (r = -0.767, p = 0.012).
Conclusions:
Periostin might be a modulator of deleterious cardiac remodeling in the chronic phase after myocardial infarction in rats.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Remodeling and Repair
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy